logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Lung Cancer Therapy Annual 7 7th Rolf A Stahel

  • SKU: BELL-4347894
Lung Cancer Therapy Annual 7 7th Rolf A Stahel
$ 31.00 $ 45.00 (-31%)

4.7

56 reviews

Lung Cancer Therapy Annual 7 7th Rolf A Stahel instant download after payment.

Publisher: Informa Healthcare
File Extension: PDF
File size: 1.81 MB
Pages: 176
Author: Rolf A. Stahel
ISBN: 9781841848655, 1841848654
Language: English
Year: 2012
Edition: 7th

Product desciption

Lung Cancer Therapy Annual 7 7th Rolf A Stahel by Rolf A. Stahel 9781841848655, 1841848654 instant download after payment.

Oncology research and practice in lung cancer continues to develop rapidly. This latest edition of Lung Cancer Therapy Annual briefs the oncology community with a review of the recent literature, emphasizing the therapeutic aspects.

It offers an update of the impact that this information will have on the day-to-day management of the lung cancer patient.

New to the Seventh Edition:

  • An update of the impact of recent developments will have on day-to-day management of lung cancer patients
  • Four new chapters on the treatment of non-small cell lung cancer (NSCLC)
  • A new chapter on thymoma

Additional topics include:

  • Oncogenic driver mutations
  • First line therapy of advanced non-small cell lung cancer without activating EGFR mutation
  • Second line therapy of non-small cell lung cancer
  • Adjunct and neoadjunct therapy of non-small cell lung cancer
  • Advances in surgery of lung cancer; advances in radiotherapy of lung cancer
  • Mesothelioma
  • Thymic tumors

Related Products